Hua-dong Yan

Ningbo, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Hepatocellular Carcinoma Risk Stratification for Cirrhosis Patients: Integrating Radiomics and Deep Learning Computed Tomography Signatures of the Liver and Spleen into a Clinical Model.

Hepatocellular Carcinoma Risk Stratification for Cirrhosis Patients: Integrating Radiomics and Deep Learning Computed Tomography Signatures of the Liver and Spleen into a Clinical Model.

Journal: Journal of clinical and translational hepatology

Published: February 26, 2025

Characterization of acute-on-chronic liver diseases: A multicenter prospective cohort study.

Characterization of acute-on-chronic liver diseases: A multicenter prospective cohort study.

Journal: World journal of hepatology

Published: November 29, 2023

The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis.

The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis.

Journal: Journal of hematology & oncology

Published: September 20, 2022

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China.

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China.

Journal: World journal of gastroenterology

Published: March 03, 2022

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.

Journal: Frontiers in endocrinology

Published: September 08, 2020

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Journal: Gut

Published: April 28, 2020

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.

Journal: Journal of hepatology

Published: April 14, 2020

Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.

Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.

Journal: Journal of gastroenterology and hepatology

Published: April 08, 2020

Fatal outcome in a liver transplant recipient with COVID-19.

Fatal outcome in a liver transplant recipient with COVID-19.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: March 31, 2020

Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohort.

Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohort.

Journal: Oncotarget

Published: May 19, 2015

Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort study.

Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort study.

Journal: Medicine

Published: January 16, 2015

Study on the relationship between hepatitis B virus genotypes and the effect of polyethylene glycol-interferon-alpha therapy on HBeAg-positive chronic hepatitis B

Study on the relationship between hepatitis B virus genotypes and the effect of polyethylene glycol-interferon-alpha therapy on HBeAg-positive chronic hepatitis B

Journal: Zhonghua nei ke za zhi

Published: February 08, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026